The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...
The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone (APP) for adults with deleterious or suspected deleterious BRCA2-mutated ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
PHOENIX — The $1.2 trillion budget package that Congress passed late Friday included everything from protection for gas stoves to restrictions on payments to the Chinese government. What it didn’t ...
Hosted on MSN
300K people in St. Louis County are eligible for big payouts in RECA settlement money – less than 1% have applied
Families who had members sickened or died from a radioactive creek in St. Louis County experienced a huge win in July when the federal government committed to paying tens of thousands of dollars in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback